Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “healthy-volunteers” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 263
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 263 pipeline programs matching "healthy-volunteers" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

263 results for “healthy-volunteers” Back to intelligence hub

Search results

Page 8 of 11
  1. SPR206

    CNS Pharmaceuticals

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  2. SPR720

    Spero Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  3. SPR720 for SAD

    Spero Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  4. SPR741

    Spero Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials
  5. SPR994

    Spero Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  6. SSS39

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Safety and Tolerability in Healthy Volunteers

    phase 1 small molecule active

    1 trial
  7. Scopolamine

    Takeda

    Healthy Volunteers

    phase 1 small molecule terminated

    1 trial
  8. Soticlestat

    Takeda

    Healthy Volunteers

    phase 1 small molecule terminated

    4 trials
  9. Soticlestat 300 mg

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  10. Stelara

    Rani Therapeutics Holdings

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  11. TAK-004

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  12. TAK-020

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  13. TAK-041

    NEUROCRINE BIOSCIENCES INC

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  14. TAK-058

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  15. TAK-063

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  16. TAK-105-a

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  17. TAK-123

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  18. TAK-227

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  19. TAK-279

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    3 trials
  20. TAK-385 T2 Formulation

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  21. TAK-418

    Takeda

    Healthy Volunteers

    phase 1 small molecule terminated

    2 trials
  22. TAK-438

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  23. TAK-438ASA

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  24. TAK-536

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.